Institutional investors hold a majority ownership of DEPO through the 90.44% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2014, these large investors purchased a net $7.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.4 Million shares of Depomed Inc
MILLENNIUM MANAGEMENT LLC Bought 1.1 Million shares of Depomed Inc
THE VANGUARD GROUP, INC. Bought 978.1 Thousand shares of Depomed Inc